Drug Shortage Report for OXYTOCIN INJECTION, USP
Report ID | 93921 |
Drug Identification Number | 02139561 |
Brand name | OXYTOCIN INJECTION |
Common or Proper name | Oxytocin Injection |
Company Name | FRESENIUS KABI CANADA LTD |
Market Status | MARKETED |
Active Ingredient(s) | OXYTOCIN |
Strength(s) | 10UNIT |
Dosage form(s) | SOLUTION |
Route of administration | INTRAMUSCULAR INTRAVENOUS |
Packaging size | 1mL |
ATC code | H01BB |
ATC description | POSTERIOR PITUITARY LOBE HORMONES |
Reason for shortage | Demand increase for the drug. |
Anticipated start date | |
Actual start date | 2019-09-30 |
Estimated end date | 2019-11-08 |
Actual end date | 2019-11-08 |
Shortage status | Resolved |
Updated date | 2019-11-28 |
Company comments | Stock Available |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 165 GALAXY BLVD, SUITE 100 TORONTO, ONTARIO CANADA M9W 0C8 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v11 | 2019-11-28 | French | Compare |
v10 | 2019-11-28 | English | Compare |
v9 | 2019-10-28 | French | Compare |
v8 | 2019-10-28 | English | Compare |
v7 | 2019-10-04 | French | Compare |
v6 | 2019-10-04 | English | Compare |
v5 | 2019-10-04 | French | Compare |
v4 | 2019-10-04 | English | Compare |
v3 | 2019-09-14 | English | Compare |
v2 | 2019-09-13 | French | Compare |
v1 | 2019-09-13 | English | Compare |
Showing 1 to 11 of 11